You are over thinking it....this will run hard as well as others ....this is just the first of more ETFs to come....this one will run like telsa... eventually they will need to have and expansion for other products related to mj and also more international exposure which is coming...I c 40 to 50$ a share maybe a forward split in 2021...
management has previously stated that the 'Tweed' brand is meant for the recreational market - they would go so far as abandoning the medical market with Tweed - Bedrocan brand will always be strictly medical
I don't remember anything about Mettrum in respect to recreational.
the best information about this is a huge article called 'the big smoke'